Novel small molecule inhibitors of biofilm formation and the novel use of previously identified compounds for inhibition of biofilm formation and applications for drug therapy and medical device coating
申请人:LININGTON Roger
公开号:US20160000079A1
公开(公告)日:2016-01-07
Novel compounds and the novel use a class of previously identified small molecules for the inhibition of biofilm formation. Inhibition of biofilm formation can play a very important role in contributing to pathogenicity. Bacteria in the biofilm state have been shown to be 10-10,000-fold less susceptible to antibiotic treatment. Estimations made by the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) attribute 65% to 80% of human infections as biofilm mediated. Consequently, biofilm formation is often responsible for chronic infections due to bacterial persistence despite antibiotic treatment.
US9596855B2
申请人:——
公开号:US9596855B2
公开(公告)日:2017-03-21
[EN] NOVEL SMALL MOLECULE INHIBITORS OF BIOFILM FORMATION AND THE NOVEL USE OF PREVIOUSLY IDENTIFIED COMPOUNDS FOR INHIBITION OF BIOFILM FORMATION AND APPLICATIONS FOR DRUG THERAPY AND MEDICAL DEVICE COATING<br/>[FR] NOUVEAUX INHIBITEURS À PETITES MOLÉCULES DE LA FORMATION DE BIOFILMS ET NOUVELLE UTILISATION DES COMPOSÉS PRÉCÉDEMMENT IDENTIFIÉS POUR INHIBER LA FORMATION DE BIOFILMS ET APPLICATIONS DE THÉRAPIE MÉDICAMENTEUSE ET DE REVÊTEMENT DE DISPOSITIFS MÉDICAUX
申请人:LININGTON ROGER
公开号:WO2014130587A1
公开(公告)日:2014-08-28
Novel compounds and the novel use a class of previously identified small molecules for the inhibition of biofilm formation. Inhibition of biofilm formation can play a very important role in contributing to pathogenicity. Bacteria in the biofilm state have been shown to be 10-10,000-fold less susceptible to antibiotic treatment. Estimations made by the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) attribute 65% to 80% of human infections as biofilm mediated. Consequently, biofilm formation is often responsible for chronic infections due to bacterial persistence despite antibiotic treatment.
Development of benzo[1,4]oxazines as biofilm inhibitors and dispersal agents against Vibrio cholerae
作者:Christopher J. A. Warner、Andrew T. Cheng、Fitnat H. Yildiz、Roger G. Linington
DOI:10.1039/c4cc07003h
日期:——
Synthesis of a library of natural product-inspired biofilm inhibitors has revealed a compound with selective and potent anti-biofilm activity against V. cholerae.